Bring on the Info

PubMed is a common tool that researchers rely on as they write grants, try to figure out where an experiment when awry, and write up their results once it actually gets done, and Bitesize Bio's Myka Ababon presents a few ways to make the most out of it.

Even before diving into her suggestions, she recommends setting up your own MyNCBI account. That way, she says, you have access to more features at PubMed and at other National Center for Biotechnology Information sites.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.